Regeneron Pharmaceuticals (REGN)
Total Liabilities
$10.02B
Quarterly · Period ending: · USD
REGN Total Liabilities
Latest reported$10.02Bperiod ending
Latest reported$10.02Bperiod ending
REGN Quarterly Total Liabilities ($13.20M → $10.02B)
Quarterly total liabilities
High-resolution chart · PNG
REGN total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 23,001,000 | |
| 24,774,000 | |
| 26,144,000 | |
| 25,347,000 | |
| 26,146,000 | |
| 26,439,000 | |
| 27,500,000 | |
| 23,900,000 | |
| 24,400,000 | |
| 25,900,000 | |
| 25,700,000 | |
| 25,500,000 | |
| 27,300,000 | |
| 26,000,000 | |
| 29,500,000 | |
| 26,500,000 | |
| 30,100,000 | |
| 28,100,000 | |
| 30,700,000 | |
| 26,400,000 | |
| 26,500,000 | |
| 24,100,000 | |
| 25,900,000 | |
| 21,200,000 | |
| 24,000,000 | |
| 22,300,000 | |
| 27,100,000 | |
| 24,600,000 | |
| 29,100,000 | |
| 19,300,000 | |
| 19,200,000 | |
| 15,800,000 | |
| 14,000,000 | |
| 12,800,000 | |
| 10,700,000 | |
| 10,900,000 | |
| 9,400,000 | |
| 9,200,000 | |
| 7,800,000 | |
| 5,600,000 | |
| 5,900,000 | |
| 13,200,000 |